Mereo Biopharma Group Plc ADR (NASDAQ:MREO) shares, rose in value on Thursday, March 27, with the stock price up by 1.69% to the previous day’s close as strong demand from buyers drove the stock to $2.41.
Actively observing the price movement in the last trading, the stock closed the session at $2.37, falling within a range of $2.4 and $2.73. Referring to stock’s 52-week performance, its high was $5.02, and the low was $2.22. On the whole, MREO has fluctuated by -1.63% over the past month.
With the market capitalization of Mereo Biopharma Group Plc ADR currently standing at about $372.90 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-25.
Wall Street analysts also predicted that the company’s y-o-y revenues would reach 11.89M.
The stock’s technical analysis shows that the price of MREO currently trading nearly -2.94% and -11.92% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 40.95, while the 7-day volatility ratio is showing 7.81% which for the 30-day chart, stands at 6.23%. Furthermore, Mereo Biopharma Group Plc ADR (MREO)’s beta value is 0.63, and its average true range (ATR) is 0.16.
A comparison of Mereo Biopharma Group Plc ADR (MREO) with its peers suggests the former has fared considerably weaker in the market. MREO showed an intraday change of 1.69% in last session, and over the past year, it shrunk by -18.86%%.
Data on historical trading for Mereo Biopharma Group Plc ADR (NASDAQ:MREO) indicates that the trading volumes over the past 10 days have averaged 1.01 and over the past 3 months, they’ve averaged 1.22 million. According to company’s latest data on outstanding shares, there are 154.73 million shares outstanding.
Nearly 8.04% of Mereo Biopharma Group Plc ADR’s shares belong to company insiders and institutional investors own 66.45% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 6.03 million shares as on 2025-03-14, resulting in a short ratio of 3.82. According to the data, the short interest in Mereo Biopharma Group Plc ADR (MREO) stood at 460.00 of shares outstanding as of 2025-03-14; the number of short shares registered in 2025-02-14 reached 7.26 million. The stock has fallen by -31.14% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the MREO stock heading into the next quarter.
